SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 17.49 |
| Enterprise Value ($M) | 16.46 |
| Book Value ($M) | 5.19 |
| Book Value / Share | 0.39 |
| Price / Book | 3.37 |
| NCAV ($M) | -2.81 |
| NCAV / Share | -0.21 |
| Price / NCAV | -6.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.90 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | -1.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.64 |
| Current Ratio | 1.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 21.29 |
| Assets | 29.28 |
| Liabilities | 24.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Global X Management CO LLC | 0.00 | -100.00 | |
| 13D | Vaiman Dany | 5.08 | ||
| 13D/A | Starke Clifford | 19.70 | 119.70 | |
| 13G | Rds Private Capital Ii, Lp | 9.79 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 92,449 | 269,127 | 34.35 | |
| 117,031 | 369,139 | 31.70 | |
| 40,746 | 115,796 | 35.19 | |
| 150,430 | 445,282 | 33.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FBIO – Fortress Biotech, Inc. | FBRX – Forte Biosciences, Inc. |
| FENC – Fennec Pharmaceuticals Inc. | FTLF – FitLife Brands, Inc. |
| GALT – Galectin Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io